This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Allurion Technologies’s 8K filing here.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Featured Articles
- Five stocks we like better than Allurion Technologies
- P/E Ratio Calculation: How to Assess Stocks
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Upcoming IPO Stock Lockup Period, Explained
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
- What is a Bond Market Holiday? How to Invest and Trade
- Cal-Maine Foods: A Defensive Play With a Cage-Free Future
